No CrossRef data available.
Article contents
Pharmaceutical Companies, Human Rights, and the Alien Tort Statute
Published online by Cambridge University Press: 19 October 2021
Abstract
On January 3, 2019, U.S. District Judge Theodore D. Chuang of the U.S. District Court of the District of Maryland took a crucial first step in redressing one of the worst human subjects research ethics violations in U.S. history.
- Type
- Columns: Health Policy Portal
- Information
- Journal of Law, Medicine & Ethics , Volume 49 , Issue 3: Malingering & Health Policy , Fall 2021 , pp. 500 - 502
- Copyright
- © 2021 The Author(s)
Footnotes
About This Column
Aaron Kesselheim serves as the editor for Health Policy Portal. Dr. Kesselheim is the JLME editor-in-chief and director of the Program On Regulation, Therapeutics, And Law at Brigham and Women’s Hospital/Harvard Medical School. This column features timely analyses and perspectives on issues at the intersection of medicine, law, and health policy that are directly relevant to patient care. If you would like to submit to this section of JLME, please contact Dr. Kesselheim at akesselheim@bwh.harvard.edu.